A survey of metabolic syndrome in first-degree relatives (fathers) of patients with polycystic ovarian syndrome

Objectives: Women with polycystic ovarian syndrome (PCOS) are at twice the risk of developing metabolic syndrome, compared to women from the general population. The aim of this study was to assess the prevalence of metabolic syndrome in the first-degree relatives (fathers) of patients suffering from PCOS.Design: This was a case control study.Setting and subjects: The study was conducted on 34 fathers of women with PCOS who presented at gynaecological clinics in Shiraz, Iran (as the case group), and 34 fathers of healthy women (as the control group).Outcomes measures: Metabolic syndrome was determined according to Adult Treatment Panel III (ATP III) and International Diabetes Federation (IDF) indices. A blood sample was obtained to assay serum insulin, blood sugar, testosterone and lipoproteins. The data were analysed using independent t-test, Fisher’s exact test and the chisquare test.Results: According to the ATP III index, the prevalence of metabolic syndrome was 29.35% in the fathers of the PCOS patients and 8.8% in the fathers of women in the control group (p-value < 0.05). According to the IDF index, this rate was 17.41 in the fathers of patients with PCOS (p-value < 0.05). According to the quantitative insulin sensitivity check and homeostasis model insulin resistance indices, the prevalence of insulin resistance, hypertension, type 2 diabetes and hypercholesterolaemia was higher in the fathers of patients with PCOS than in the control group, but the difference was not significant (p-value > 0.05).Conclusion: The fathers of the women with PCOS were at a higher risk of developing metabolic syndrome, hypertension, dyslipidaemia, impaired glucose tolerance and diabetes.Keywords: metabolic disorders, polycystic ovarian syndrome, Insulin resistance, impaired glucose toleranc

Cardiovascular risk factors in first relative member of patients with polycystic ovarian syndrom in Shiraz, Iran

Background and Objective: There is a genetic background for polycystic ovary syndrome (PCOS). Due to increase metabolic disorders, lipoproteins, impaired glucose tolerance, and hypertension in PCOS patients, this study was done to determine the cardiovascular risk factors in first relative member of patients with polycystic ovarian syndrom in Shiraz, Iran. Materials and Methods: This case - control study was carried out on 107 parents and siblings of women with PCOS as cases and 107 non-PCOS parents and siblings of women as controls in Shiraz, Iran during 2007-08. Demographic characteristic, BMI, obesity and blood pressure were recorded for all subjects. Serum lipoproteins including total cholestrol, triglyceride, LDL, HDL and fasting blood sugar were measured in cases and controls. Data were analyzed using SPSS-16.5, independent t-test, Chi-Square and Kappa tests. Results: 35.3%, 26.5%, 11.76% and 5.8% of fatheres in cases were considered as overweight class I, class II, class III of obesity, respectively when compared to controls. This differecne was significant (P<0.05). Waist –hip ratio in mothers in cases (25.6%) and controls (17.9%) were higher than 0.85. Waist –hip ratio among the sisters in case and control groups were 23.5% and 17.6%, respectively (P<0.05). Hypertension was observed in 12.2% of cases and 3.7% of controls. This difference was not significant. High level of triglyceride were determined in 14.94% of cases and 6.5% of controls. A significant correlation was found between BMI and diabete II in case and control groups (P<0.05). Disorder in glucose tolerance test (GTT) in case and control goups were 19.62% and 7.47%, respectively (P<0.05). The obesity was found in 18.7%, 6.54% in cases and controls with disorder in GTT (P<0.05). Conclusion: This study showed that obesity, central obesity, high level of serum lipoproteins and hypertension among first relative member of patients with PCOS are significantly higher than the controls

Serum lipoproteins level in first degree relatives of women with polycystic ovarian syndrome

Background and Objective: Polycystic ovarian syndrome (PCOS) is one of the most prevalent (6-10%) endocrine glands disorders among child - bearing women. In addition to the patients, their first degree relatives are exposed to some risk factors such as abnormal lipoproteins. Due to high prevalence PCOS among women and the role of genetic factors in this abnormality, it is necessary to recognize high risk people particularly among first degree relative. Therefore this study was conducted to determine the level of serum lipoproteins in first degree relatives of patients with PCOS. Materials and Methods: This case control study was done on 107 individuals of the first degree relatives of PCOS patients as cases and 107 normal individuals of the first degree of non-PCOS as controls in Shiraz, Iran during 2009. Participants completed a test assessing demographics and blood sample were taken from all participants in order to assay serum lipoproteins including total cholesterol, LDL, HDL and triglyceride. Data was analyzed by means of independent t-test and Fisher's exact test as well as Chi-Square. Results: The means±SD of total cholesterol, HDLc and triglyceride in cases was 191±31.64, 167±4.06 and 191±31.64 mg/dl, respectively. The means±SD of total cholesterol, LDLc and triglyceride in controls was 158.25±18.25, 123±21.33 and 120.42±17.11 mg/dl, respectively. Serum level differences of LDL and triglyceride in cases and controls were significant (P<0.05). The means±SD of HDLc in cases and controls was 40.06±6.95 and 45.9±6.7 mg/dl, respectively (P<0.05). Conclusion: This study showed that the serum level of lipoproteins in the first degree relatives of PCOS patients is significant higher than non-PCOS